The hit Wegovy weight-loss drug is on track for sales of over $4 billion this year in the U.S. alone, despite its manufacturer Novo Nordisk struggling to.
Coppell Advisory Solutions Corp. acquired a new stake in shares of Novo Nordisk A/S (NYSE:NVO – Get Rating) in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor acquired 11,812 shares of the company’s stock, valued at approximately $1,599,000. Other institutional investors and […]
Coppell Advisory Solutions Corp. acquired a new stake in Novo Nordisk A/S (NYSE:NVO – Get Rating) in the fourth quarter, HoldingsChannel reports. The fund acquired 11,812 shares of the company’s stock, valued at approximately $1,599,000. Other hedge funds and other institutional investors also recently modified their holdings of the company. Roundview Capital LLC lifted its […]
Wallace Advisory Group LLC purchased a new stake in Novo Nordisk A/S (NYSE:NVO – Get Rating) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund purchased 6,395 shares of the company’s stock, valued at approximately $865,000. Other hedge funds have also […]
Alyeska Investment Group L.P. trimmed its position in shares of Novo Nordisk A/S (NYSE:NVO – Get Rating) by 17.0% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 388,090 shares of the company’s stock after selling 79,719 shares during the period. […]